Sema4 to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021
October 19, 2021 16:05 ET
|
Sema4
STAMFORD, Conn., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced it will release financial results for...
Sema4 Appoints Computational Biology Expert Gustavo Stolovitzky as Chief Science Officer
September 13, 2021 08:00 ET
|
Sema4
STAMFORD, Conn., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Sema4, an AI-driven genomic and clinical data intelligence platform company, today announced the appointment of Gustavo Stolovitzky, PhD, to the...
Sema4 Launches Sema4 Elements™, a Portfolio of Data Science-Driven Products and Services to Support Reproductive and Generational Health
September 09, 2021 08:00 ET
|
Sema4
STAMFORD, Conn., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Sema4, an AI-driven genomic and clinical data intelligence platform company, today announced the launch of Sema4 Elements™, a portfolio of...
Avera Health and Sema4 Announce Collaboration to Advance Precision Oncology Care
August 11, 2021 08:00 ET
|
Sema4
SIOUX FALLS, S.D and STAMFORD, Conn., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Avera Health, an integrated regional health care system that serves 300 locations across the Upper Midwest, and Sema4, a...
Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company
July 22, 2021 09:15 ET
|
Sema4
Sema4 Holdings Corp (“Sema4”) to debut on Nasdaq as a publicly traded company dedicated to transforming healthcare by applying artificial intelligence and machine learning to multidimensional,...
SomaLogic launches the SomaSignal™ Proteomics for Precision Medicine Initiative with healthcare innovators: Emory University, Intermountain Healthcare, CommonSpirit Health and UCHealth
May 20, 2021 10:00 ET
|
SomaLogic, Inc.
BOULDER, Colo., May 20, 2021 (GLOBE NEWSWIRE) -- SomaLogic announced today its SomaSignal™ Proteomics for Precision Medicine Initiative, the first large-scale, clinically focused partnership effort...
Syapse Announces Research Collaboration with the FDA Focused on the Regulatory Use of Real-World Evidence
August 14, 2019 06:00 ET
|
Syapse
SAN FRANCISCO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Syapse and the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) have signed a multi-year Research Collaboration Agreement...